Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin.
about
Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albuminAlbumin-binding PARACEST agentsp-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albuminRole of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients.Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood studyGuanidinylations of albumin decreased binding capacity of hydrophobic metabolites.Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.Binding affinity and capacity for the uremic toxin indoxyl sulfateProtein binding characteristics of 2'-benzoyloxycinnamaldehyde.Indoxyl sulfate induces complex redox alterations in mesangial cells.Effect of biological confinement on the photophysics and dynamics of a proton-transfer phototautomer: an exploration of excitation and emission wavelength-dependent photophysics of the protein-bound drug.In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.EPR studies of intermolecular interactions and competitive binding of drugs in a drug-BSA binding model.Indoxyl Sulfate Elimination in Renal Replacement Therapy: Influence of Citrate- versus Acetate-Buffering Component during Bicarbonate Dialysis
P2860
Q27664984-725AE871-95D3-4F75-8351-DE4A9F89A06AQ31114012-C8DB5510-28D4-4E9C-8553-FAB621D77F11Q33560454-22D9EC2F-4A0F-4DE8-B4AA-0455352EDC1BQ35581476-0061F050-F19B-4EFE-8A40-063D396751A6Q37468522-0BFF7A72-C0B0-46D3-BA13-6E6B991FA9C9Q38222867-3EA4DD49-72E2-4585-88B5-9E6BD5B36DCEQ39309486-6855321F-4B3A-4100-B475-92F95AB48444Q40978843-4ABA57A2-BE63-4BF4-B1E5-46A33DFB5004Q41001222-8A0896A5-2F60-466D-ACE1-EE3ED769685CQ41907635-2B76FF20-ED30-492A-B9AA-92BA314C67DAQ46658157-7329DD2B-B4F3-4990-8170-6E3747BB4A5FQ46910093-804C1A9F-10C8-4CC8-ABE5-82E55650BA3DQ50505675-6B69A739-A596-4611-AC69-E956AB041355Q51099987-0403EA46-8999-4E67-B0A1-6AF73EC8267FQ51226854-D350EB2E-4E23-408B-B995-4F8FF53B55C9Q58776868-2C08C955-D0D2-4F8F-A276-D4B73570E807
P2860
Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Interaction mechanism between ...... site I of human serum albumin.
@en
Interaction mechanism between ...... site I of human serum albumin.
@nl
type
label
Interaction mechanism between ...... site I of human serum albumin.
@en
Interaction mechanism between ...... site I of human serum albumin.
@nl
prefLabel
Interaction mechanism between ...... site I of human serum albumin.
@en
Interaction mechanism between ...... site I of human serum albumin.
@nl
P2093
P356
P1476
Interaction mechanism between ...... site I of human serum albumin.
@en
P2093
P304
P356
10.1023/A:1011014629551
P577
2001-04-01T00:00:00Z